Christoph Rudiger Antz Insider Profile
4 Followers
Christoph Rudiger Antz, Chief Executive Officer, Director at Veraxa Biotech, holds 5.00K shares in Veraxa Biotech (Ticker: VRXA). Most recently, Christoph Rudiger Antz Bought 5,000 shares of Veraxa Biotech on Aug 31, 2026 for an estimated value of $7.65K.
Christoph Rudiger Antz has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Christoph Rudiger Antz's holdings
Insider Roles
Chief Executive Officer, Director
Roles that Christoph Rudiger Antz holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Christoph Rudiger Antz
Christoph Rudiger Antz's Trading History
List of latest transactions for each holding click on a transaction to see Christoph Rudiger Antz's performance on stock
You May Also Like
Christoph Rudiger Antz insider profile FAQ
What is the percentage of profitable transactions made by Christoph Rudiger Antz?
The percentage of profitable transactions made by Christoph Rudiger Antz is ―.
What is the average return per transaction made by Christoph Rudiger Antz?
The average return per transaction made by Christoph Rudiger Antz is ―.
What stocks does Christoph Rudiger Antz hold?
Christoph Rudiger Antz holds: VRXA stocks.
What was Christoph Rudiger Antz’s latest transaction?
Christoph Rudiger Antz latest transaction was an Informative Buy of $7.65K.
What was Christoph Rudiger Antz's most profitable transaction?
Christoph Rudiger Antz’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Christoph Rudiger Antz's role in Veraxa Biotech?
Christoph Rudiger Antz's role in Veraxa Biotech is Chief Executive Officer, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.